Dr. Reddy's Laboratories Ltd. · NSE:DRREDDY
Dr. Reddy's Laboratories — Fact Sheet (September 2008)
12 slides from Dr. Reddy's Laboratories's fact sheet, September 2008
Slide 1: Dr.REDDY'S
Dr.REDDY’S Our identity is a sunny abstract that can be interpreted as a person with outstretched arms. It expresses joy, warmth, vitality, and the boundless possibilities in the search for a healthier life. The form sums up our essential driving force in three words: LIFE. RESEARCH . HOPE Research.
Slide 2: About Dr. Reddy's
About Dr. Reddy's Dr. Reddy's Laboratories is a global, vertically integrated pharmaceutical company with a presence across the value chain through its various businesses, including PSA! (Pharmaceutical Services & Active Ingredients), Global Generics and Innovation (Discovery Research, Biologics and
Slide 3: Global presence
Global presence » Headquartered in India e Wholly-owned subsidiaries in the US, UK, Russia, Germany, Brazil, New Zealand, Turkey and Mexico Joint ventures in China, South Africa and Australia . Representative offices in 16 countries « Third party distribution setups in 23 countries « North America «
Slide 4: Employees
Employees 9500 + People world wide 1700 + Research & Scientific staff 3300 + Marketing & Sales force 3300 + Manufacturing staff 40 + Nationalities eS Best Pharma Dun & Bradstreet American Express Corporate Awards 2007 Best workplace in Biotech / Pharma Industry by Great Place To Work Institute and T
Slide 5: Rankings
Rankings « Among the top ten pharmaceutical companies from India * 5th largest branded generic player in Germany * Ranked 15 in the retail segment in Russia * Among the top 3 API players globally » Top 3 ANDA and DMF pipeline in the USA * Among the largest players in the Custom Pharmaceutical Servic
Slide 6: Financial Snapshot
Financial Snapshot World-wide Revenues Revenue by Geography for FY 08 1600 | (U50.6ind 38 99 00 01 G2 03 DE D5 O65 OF OB Financial Yer 1 Upsides, $ Mn Russia & CIS 11% 1% North America PSAI (107) g=+2 Global Generics North America g=+62% Germany g=+20% Russia g=+21% India g=+9% Others BEGIN 8=+8% Gl
Slide 7: Corporate Citizenship
soving £, RS Yes Corporate Citizenship We are guided by the ‘Triple Bottom Line’ approach that ensures our care and concern ©& zB for the environment, resource conservation, socially responsible engagement of % 3 employees and economically sustainable relationships with customers, suppliers, %, s bu
Slide 8: Pharmaceutical Services & Active Ingredients
Pharmaceutical Services & Active Ingredients Custom Pharmaceutical Services Preferred partner for innovator companies by providing a complete range of services necessary to take innovations to the market with greater speed, efficiency and lower capital expenditures. Active Pharmaceutical Ingredients
Slide 9: Generics
Generics Branded Formulations Helping people lead healthier lives by constantly delivering high quality products combined with innovative marketing in 46 countries. A portfolio of over 200 products in core therapeutic areas gives us a competitive edge. The network strength of over 2,500 strong field
Slide 10: Innovation
Innovation Discovery Research Our Discovery Research programs span several Focus Therapeutic Areas. Internally researched New Chemical Entity (NCE) pipeline consists of analog and first-in-class treatments addressing unmet needs with a potential to make a significant difference in patients’ lives. O
Slide 11: Biologics
Biologics Reditux™ (generic rituximab) ™, the world's first biosimilar monoclonal anti-body used in the treatment of Non-Hodgkin's Lymphoma was launched. We are the first company in India to fully develop, in-house, a biogeneric, Grafeel (generic Filgrastim), right from the molecular biology phase u
Slide 12: Infrastructure
Infrastructure Active Pharmaceutical Ingredients Eight USFDA-approved facilities with 2 million liters of reaction volume. 1 USFDA-approvable cytotoxic facility. Over 100 molecules developed, 60 molecules marketed, 100 DMFs in the US. State-of-the-art facility in Mexico to meet innovator company nee
Dr. Reddy's Laboratories — Fact Sheet (September 2008) on 6ix